These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23250513)

  • 1. Treatment of acute decompensation of maple syrup urine disease in adult patients with a new parenteral amino-acid mixture.
    Servais A; Arnoux JB; Lamy C; Hummel A; Vittoz N; Katerinis I; Bazzaoui V; Dubois S; Broissand C; Husson MC; Berleur MP; Rabier D; Ottolenghi C; Valayannopoulos V; de Lonlay P
    J Inherit Metab Dis; 2013 Nov; 36(6):939-44. PubMed ID: 23250513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
    Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P
    Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
    Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new protein substitute for adolescents and adults with maple syrup urine disease (MSUD).
    Hallam P; Lilburn M; Lee PJ
    J Inherit Metab Dis; 2005; 28(5):665-72. PubMed ID: 16151896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the acute crisis in maple syrup urine disease.
    Nyhan WL; Rice-Kelts M; Klein J; Barshop BA
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):593-8. PubMed ID: 9641714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid-free formulas in France and Germany: A retrospective observational study.
    de Lonlay P; Posset R; Mütze U; Mention K; Lamireau D; Schiff M; Servais A; Arnoux JB; Brassier A; Dao M; Douillard C; Ottolenghi C; Pontoizeau C; Miotto F; Le Mouhaër J
    JIMD Rep; 2021 May; 59(1):110-119. PubMed ID: 33977036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
    Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total parenteral nutrition therapy of toxic maple syrup urine disease.
    Townsend I; Kerr DS
    Am J Clin Nutr; 1982 Aug; 36(2):359-65. PubMed ID: 6808824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration.
    Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK
    Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
    Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful repair and postoperative management of tetralogy of Fallot in a patient with maple syrup urine disease.
    Fukutomi M; Kitamura S; Kawachi K; Tsuji T; Hashimoto K; Yoshioka A
    Heart Vessels; 1993; 8(1):48-51. PubMed ID: 8454563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
    Lie IE; Haugstad S; Holm H
    Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sodium phenylbutyrate treatment in acute management of maple syrup urine disease attacks: a single-center experience.
    Zubarioglu T; Dede E; Cigdem H; Kiykim E; Cansever MS; Aktuglu-Zeybek C
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):121-126. PubMed ID: 33180043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment.
    Kanakis MG; Michelakakis H; Petrou P; Koutsandrea C; Georgalas I
    BMC Ophthalmol; 2016 Oct; 16(1):170. PubMed ID: 27716111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT; Heidenreich R; Kaplan P; Levine F; Mazur A; Palmieri MJ; Yudkoff M; Segal S
    N Engl J Med; 1991 Jan; 324(3):175-9. PubMed ID: 1898534
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensory-motor polyneuropathy occurring in variant maple syrup urine disease.
    Harty S; King MD; McCoy B; Costigan D; Treacy EP
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S209-11. PubMed ID: 18855118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.